SION (STOCKS)
Sionna Therapeutics, Inc. Common Stock
$36.000000
+0.080000 (+0.22%)
Prev close: $35.920000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Cloonan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,624.51M
- Employees
- 48
- P/E (TTM)
- -18.78
- P/B (TTM)
- 5.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
7
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.60 | $-0.52 | -0.0756 | -14.42% |
|
Dec 2025 (Q4)
|
$-0.46 | $-0.55 | +0.0894 | +16.27% |
|
Sep 2025 (Q3)
|
$-0.46 | $-0.49 | +0.0340 | +6.88% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.57 | +0.1561 | +27.57% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $13.36M |
| Operating Expenses | $98.92M |
| Research and Development | $65.56M |
| Other Operating Expenses | $33.36M |
| Operating Income/Loss | -$98.92M |
| Income/Loss From Continuing Operations After Tax | -$85.57M |
| Income/Loss From Continuing Operations Before Tax | -$85.57M |
| Net Income/Loss | -$85.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$85.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$85.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$411.51 |
| Diluted Earnings Per Share | -$411.51 |
| Basic Average Shares | 134,868,809 |
| Diluted Average Shares | 134,868,809 |
| Assets | $305.04M |
| Current Assets | $220.96M |
| Cash | $289.90M |
| Noncurrent Assets | $84.08M |
| Fixed Assets | $2.07M |
| Other Non-current Assets | $82.01M |
| Liabilities | $16.83M |
| Current Liabilities | $9.78M |
| Wages | $1.49M |
| Other Current Liabilities | $8.28M |
| Noncurrent Liabilities | $7.06M |
| Equity | $288.21M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $288.21M |
| Liabilities And Equity | $305.04M |
| Net Cash Flow From Operating Activities | -$71.85M |
| Net Cash Flow From Operating Activities, Continuing | -$71.85M |
| Net Cash Flow From Investing Activities | $47.27M |
| Net Cash Flow From Investing Activities, Continuing | $47.27M |
| Net Cash Flow From Financing Activities | $5.21M |
| Net Cash Flow From Financing Activities, Continuing | $5.21M |
| Net Cash Flow | -$19.37M |
| Net Cash Flow, Continuing | -$19.37M |
| Comprehensive Income/Loss | -$85.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$85.95M |
| Other Comprehensive Income/Loss | $54.44M |
| Other Comprehensive Income/Loss Attributable To Parent | -$385.00K |